By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Horizon Therapeutics 

533 Bryant Street
Building 6
Palo Alto  California  94301  U.S.A.
Phone: 650-324-8700 Fax: 650-618-0398


Company News
Horizon Therapeutics and Nitec Pharma AG Complete Merger and Combine Businesses in an All-stock Transaction 4/2/2010 6:46:29 AM
Horizon Therapeutics Said Near Deal to Buy Nitec Pharma AG 4/1/2010 7:29:37 AM
Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 10/26/2009 9:09:26 AM
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer 6/30/2009 9:45:07 AM
Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain 6/2/2009 8:53:38 AM
Horizon Therapeutics Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, California 3/23/2009 11:50:13 AM
Horizon Therapeutics Announces Senior Management Appointments 1/6/2009 11:23:36 AM
Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 12/2/2008 9:29:34 AM
Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer 10/9/2008 8:32:05 AM
Horizon Therapeutics Announces Corporate Relocation to the Chicago Area 7/31/2008 9:28:35 AM